These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11145711)

  • 1. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis.
    Scholzen TE; Steinhoff M; Bonaccorsi P; Klein R; Amadesi S; Geppetti P; Lu B; Gerard NP; Olerud JE; Luger TA; Bunnett NW; Grady EF; Armstrong CA; Ansel JC
    J Immunol; 2001 Jan; 166(2):1285-91. PubMed ID: 11145711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cutaneous inflammation by angiotensin-converting enzyme.
    Scholzen TE; Ständer S; Riemann H; Brzoska T; Luger TA
    J Immunol; 2003 Apr; 170(7):3866-73. PubMed ID: 12646655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P.
    Sturiale S; Barbara G; Qiu B; Figini M; Geppetti P; Gerard N; Gerard C; Grady EF; Bunnett NW; Collins SM
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11653-8. PubMed ID: 10500232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
    Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
    FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.
    Babu RJ; Kikwai L; Jaiani LT; Kanikkannan N; Armstrong CA; Ansel JC; Singh M
    Pharm Res; 2004 Jan; 21(1):108-13. PubMed ID: 14984264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurogenic plasma leakage in mouse airways.
    Baluk P; Thurston G; Murphy TJ; Bunnett NW; McDonald DM
    Br J Pharmacol; 1999 Jan; 126(2):522-8. PubMed ID: 10077247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral endopeptidase and angiotensin-converting enzyme -- key enzymes terminating the action of neuroendocrine mediators.
    Scholzen TE; Luger TA
    Exp Dermatol; 2004; 13 Suppl 4():22-6. PubMed ID: 15507108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of neuropeptides and their degrading enzymes in ACD.
    Bak H; Lee WJ; Lee YW; Chang SE; Choi JH; Kim MN; Kim BJ; Choi YS; Suh HS
    Clin Exp Dermatol; 2010 Apr; 35(3):318-23. PubMed ID: 20030666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleic acid exhibits an expressive anti-inflammatory effect in croton oil-induced irritant contact dermatitis without the occurrence of toxicological effects in mice.
    Pegoraro NS; Camponogara C; Cruz L; Oliveira SM
    J Ethnopharmacol; 2021 Mar; 267():113486. PubMed ID: 33091495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The control of microvascular permeability and blood pressure by neutral endopeptidase.
    Lu B; Figini M; Emanueli C; Geppetti P; Grady EF; Gerard NP; Ansell J; Payan DG; Gerard C; Bunnett N
    Nat Med; 1997 Aug; 3(8):904-7. PubMed ID: 9256283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors.
    Gaffal E; Cron M; Glodde N; Tüting T
    Allergy; 2013 Aug; 68(8):994-1000. PubMed ID: 23889474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbated and prolonged allergic and non-allergic inflammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin.
    Kawase Y; Hoshino T; Yokota K; Kuzuhara A; Kirii Y; Nishiwaki E; Maeda Y; Takeda J; Okamoto M; Kato S; Imaizumi T; Aizawa H; Yoshino K
    J Invest Dermatol; 2003 Sep; 121(3):502-9. PubMed ID: 12925208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions.
    Homey B; von Schilling C; Blümel J; Schuppe HC; Ruzicka T; Ahr HJ; Lehmann P; Vohr HW
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):83-94. PubMed ID: 9875302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model.
    Bánvölgyi A; Pálinkás L; Berki T; Clark N; Grant AD; Helyes Z; Pozsgai G; Szolcsányi J; Brain SD; Pintér E
    J Neuroimmunol; 2005 Dec; 169(1-2):86-96. PubMed ID: 16188326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides enhance irritant and allergic contact dermatitis.
    Gutwald J; Goebeler M; Sorg C
    J Invest Dermatol; 1991 May; 96(5):695-8. PubMed ID: 1708795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice.
    Jung SH; Sun X; Ryu WS; Yang BS
    Br J Dermatol; 2013 Jan; 168(1):112-9. PubMed ID: 23020072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant neutral endopeptidase attenuates substance P-induced plasma extravasation in the guinea pig skin.
    Rubinstein I; Iwamoto I; Ueki IF; Borson DB; Nadel JA
    Int Arch Allergy Appl Immunol; 1990; 91(3):232-8. PubMed ID: 1693912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice.
    Yamaoka J; Kawana S
    J Dermatol Sci; 2007 Nov; 48(2):123-32. PubMed ID: 17692507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-concentration topical capsaicin may abolish the clinical manifestations of allergic contact dermatitis by effects on induction and elicitation.
    Andersen HH; Elberling J; Arendt-Nielsen L
    Med Hypotheses; 2017 Feb; 99():53-56. PubMed ID: 28110699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.